Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
about
Targeting hypoxic response for cancer therapyMolecular Mechanisms Underlying Peritoneal EMT and FibrosisEpithelial to Mesenchymal Transition in a Clinical PerspectiveTumor stroma as targets for cancer therapyLinking metabolism and epigenetic regulation in development of hepatocellular carcinomaEffect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma riskEpigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.Expression of MACC1 and c-Met in human gastric cancer and its clinical significance.Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer.cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transitionRat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cellsOverexpression of c-Met increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivoHigh circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients.Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Goosecoid promotes the metastasis of hepatocellular carcinoma by modulating the epithelial-mesenchymal transition.Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cellsPreclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistanceProteomic signatures associated with p53 mutational status in lung adenocarcinoma.Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinomaOxidation of heat shock protein 60 and protein disulfide isomerase activates ERK and migration of human hepatocellular carcinoma HepG2.Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.Hepatocyte growth factor increases the invasive potential of PC-3 human prostate cancer cells via an ERK/MAPK and Zeb-1 signaling pathway.Role of the Slug Transcription Factor in Chemically-Induced Skin CancerA randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatmentInsufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma.Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer.Tumor microenviroment and hepatocellular carcinoma metastasis.Bone metastases in hepatocellular carcinoma: an emerging issue.New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.Transforming Growth Factor β1 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells Via Up-Regulation of Connective Tissue Growth Factor.SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.Plasticity of tumor cell invasion: governance by growth factors and cytokines.Co-targeting c-Met and COX-2 leads to enhanced inhibition of lung tumorigenesis in a murine model with heightened airway HGF.
P2860
Q26767351-773B45C0-81E1-4DCF-9F44-EC4AE66F3DBEQ26768501-4DDCC160-3C43-4C39-97C4-28E228D5B702Q26783554-CE239906-251F-4BCE-807F-11256F959147Q27015980-350FF125-6D3E-487A-9953-C08D21195516Q27023744-ACAF5867-8C2B-4AA9-8CD6-6828B6555481Q28646415-4F2AE150-09A3-4C11-B1E7-E91234BC8E8BQ31118547-E339102B-5854-401D-B7C7-E8C41BB80F35Q33643400-C96EA9CE-AF10-4BE0-B34B-0E3ABC790FCDQ33676514-9B11FFA1-FE32-4440-AB80-D13CCE3745EBQ33815876-39E4BFAD-F58C-45BC-BF2D-AAA33C79B209Q33830894-DB93AD2B-3358-4549-9262-8644CB5C44F6Q34105226-A456DC72-B2F1-41D3-9D48-A57176064FD7Q34141440-84DF3AC2-E8EA-493C-9A1D-E609C306D42CQ34221586-0BED2006-7E16-4368-A990-BCA4AEC967ABQ34388854-763352B4-A6F4-4757-8AB0-CB1EDBD4A02EQ34400426-5B2D2C7F-28CC-4E11-A603-9A808A4E1671Q34690834-BCA618E1-BBEC-4E46-95E8-F6078DDD6209Q34995167-EAB1056A-4547-441E-9E19-0BE8915509AEQ35045419-D0D96420-46DF-4D52-8DC0-82568760686EQ35492010-E9641219-4579-4E67-ADB1-716D4D539D67Q35783090-0FD5A319-3403-4987-95A1-50E441F9E32AQ35913323-1AAA3587-DD4B-4F37-A4DB-66A47206470EQ35915748-22208BAE-6740-48D1-86E9-20BAF0D49F13Q36294465-EE54CE0E-C558-4788-AC8E-F79BA1AC5ED6Q36492673-74AFB1BA-3963-4574-952C-734CA1D5F1D9Q36502905-0B6CB2B3-9BE4-43D0-B159-F1B98617BCCFQ36638287-5A59999A-18DC-474F-BCBD-59A398D5CA39Q37215092-4AE72DEA-A9E5-4EB9-94E3-A9199684FCAAQ37348249-BD2B1140-F656-426D-AE98-C04353CF52F9Q37646934-AE98489A-5035-42BA-B046-C7A8AEDDF120Q37650102-1172E42A-C304-43ED-9E79-66E5B153F22CQ38121570-6ADA1379-7E74-4350-99BC-9E09A18A3735Q38172848-A2C863F7-AD28-43A9-9FD2-5BD839FEF784Q38550876-3ECB5D85-C012-4B8C-8A2E-30AD4915546BQ38674137-6FCE186B-44DA-4511-B100-A45FA7E8611FQ38738394-3321D36D-0325-440C-98AB-40100C1D8EEEQ38766773-96A3326F-692D-4C90-9FDB-528DD3539A3AQ38809698-566CF541-53EF-4562-90F2-936E676DEF82Q38963431-DEADD563-BD03-48EF-8955-51010A529865Q38972229-8354F7A5-262C-4A73-9148-83AFA473C8A9
P2860
Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocyte growth factor upreg ...... oma via Akt and COX-2 pathways
@en
Hepatocyte growth factor upreg ...... ma via Akt and COX-2 pathways.
@nl
type
label
Hepatocyte growth factor upreg ...... oma via Akt and COX-2 pathways
@en
Hepatocyte growth factor upreg ...... ma via Akt and COX-2 pathways.
@nl
prefLabel
Hepatocyte growth factor upreg ...... oma via Akt and COX-2 pathways
@en
Hepatocyte growth factor upreg ...... ma via Akt and COX-2 pathways.
@nl
P2860
P1476
Hepatocyte growth factor upreg ...... oma via Akt and COX-2 pathways
@en
P2093
Olorunseun O Ogunwobi
P2860
P2888
P304
P356
10.1007/S10585-011-9404-X
P577
2011-07-10T00:00:00Z